Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4414 Target Snapshot

Plasmepsin II · SINGLE PROTEIN · Plasmodium falciparum

654Compounds
76Assays
0Approved Drugs
721.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P46925. Use UniProt P46925 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P46925 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Plasmepsin II as ChEMBL target CHEMBL4414, mapped to UniProt P46925. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Plasmepsin II
SINGLE PROTEIN · Plasmodium falciparum
As of 2026-09-14
ChEMBL target ID
CHEMBL4414
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P46925
Plasmepsin II
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Plasmepsin II is the right protein anchor across sources, using UniProt P46925 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPlasmepsin II
UniProt AccessionP46925
Component TypeProtein
Sequence Length453 aa

Plasmepsin II

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Plasmepsin II, mapped to UniProt P46925. Sequence length is 453 aa.

Mapped IDP46925
Review namePlasmepsin II
OrganismPlasmodium falciparum
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC50421.0
KI300.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1208799 10.0 Ki 0.1 Preclinical
CHEMBL1209499 10.0 Ki 0.1 Preclinical
CHEMBL257594 9.89 IC50 0.13 Preclinical
CHEMBL411559 9.7 Ki 0.2 Preclinical
CHEMBL1213687 9.4 Ki 0.4 Preclinical
CHEMBL296588 9.38 IC50 0.42 Clinical
CHEMBL112598 9.3 Ki 0.5 Preclinical
CHEMBL231522 9.3 Ki 0.5 Preclinical
CHEMBL113208 9.25 Ki 0.56 Preclinical
CHEMBL1213687 9.23 IC50 0.59 Preclinical
Distribution

pChEMBL Value Distribution

47
5.0
58
5.5
115
6.0
97
6.5
97
7.0
76
7.5
80
8.0
30
8.5
18
9.0
2
9.5
pChEMBL
Assay Landscape

Assay Landscape

76
Total Assays
593
Tested Compounds
1
Assay Types
Binding — 76 assays, 593 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 62 496 6.8
assay format 13 97 7.3
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine